{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:30Z","timestamp":1791925410025,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T00:00:00Z","timestamp":1537574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"DPIP\/ISEC Programme of the European Union"},{"DOI":"10.13039\/501100011039","name":"Swiss Centre of Applied Human Toxicology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011039","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011039","name":"Swiss Centre of Applied Human Toxicology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011039","id-type":"DOI","asserted-by":"crossref"}]},{"name":"RADARS System, Denver Health and Hospital Authority, Denver, US"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00228-018-2550-1","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T23:54:42Z","timestamp":1537574082000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: profiling and relation to sales data"],"prefix":"10.1007","volume":"75","author":[{"name":"Euro-DEN Research Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8758-7972","authenticated-orcid":false,"given":"C .","family":"Lyphout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. R.","family":"Margolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. I.","family":"Dargan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Dines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Heyerdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"Hovda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Giraudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bucher-Bartelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,22]]},"reference":[{"key":"2550_CR1","unstructured":"EMCDDA. Legal topic overviews: classification of controlled drugs. [Internet]. Lisbon; 2016. Available from: \n                    http:\/\/www.emcdda.europa.eu\/html.cfm\/index146601EN.html"},{"key":"2550_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD (2012) Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend 125:8\u201318","journal-title":"Drug Alcohol Depend"},{"key":"2550_CR3","unstructured":"BNF. Hypnotics and anxiolytics [Internet]. 2013 [cited 2017 Dec 12]. Available from: \n                    https:\/\/www.bnf.org"},{"key":"2550_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000337028","volume":"18","author":"A Casati","year":"2012","unstructured":"Casati A, Sedefov R, Pfeiffer-Gerschel T (2012) Misuse of medicines in the European union: a systematic review of the literature. Eur Addict Res 18:228\u2013245","journal-title":"Eur Addict Res"},{"key":"2550_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","volume":"9","author":"N Gunja","year":"2013","unstructured":"Gunja N (2013) The clinical and forensic toxicology of Z-drugs. J. Med. Toxicol. 9:155\u2013162","journal-title":"J. Med. Toxicol."},{"key":"2550_CR6","unstructured":"Home Office. The Misuse of Drugs Act 1971 (Modification) Order 2003. Br Med J. 2003;2\u20133. Available from: \n                    https:\/\/www.gov.uk\/government\/publications\/controlled-drugs%2D%2D7"},{"key":"2550_CR7","unstructured":"EMA. Zerene (zaleplon): Withdrawal of the marketing authorisation in the European Union. 2012"},{"key":"2550_CR8","unstructured":"EMA. Sonata: withdrawal of the marketing authorisation in the European Union [Internet]. 2015. Available from: \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Public_statement\/2015\/10\/WC500195873.pdf"},{"key":"2550_CR9","unstructured":"United Nations Office on Drugs and Crime. The non-medical use of prescription drugs Policy direction issues [Internet]. Vienna; 2011. Available from: \n                    http:\/\/www.unodc.org\/docs\/youthnet\/Final_Prescription_Drugs_Paper.pdf"},{"key":"2550_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0022-3956(90)90045-R","volume":"24","author":"J Cole","year":"1990","unstructured":"Cole J, Chiarello R (1990) The benzodiazepines as drugs of abuse. J Psychiatr Res 24:135\u2013144","journal-title":"J Psychiatr Res"},{"key":"2550_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00004714-199008000-00002","volume":"10","author":"R Griffiths","year":"1990","unstructured":"Griffiths R, Wolf B (1990) Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol 10:237\u2013243","journal-title":"J Clin Psychopharmacol"},{"key":"2550_CR12","first-page":"269","volume":"23","author":"L Zawertailo","year":"2003","unstructured":"Zawertailo L, Busto U, Kaplan H, Greenblatt D, Sellers E (2003) Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. J Clin Psychopharmacol 23:269\u2013280","journal-title":"J Clin Psychopharmacol"},{"key":"2550_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/jcp.0b013e31815a2542","volume":"27","author":"S Abanades","year":"2007","unstructured":"Abanades S, Farr\u00e9 M, Barral D, Torrens M, Neus Closas Y, Langohr K et al (2007) Relative abuse liability of +-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users. J Clin Psychopharmacol 27:625\u2013638","journal-title":"J Clin Psychopharmacol"},{"key":"2550_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1192\/bjp.bp.114.149252","volume":"205","author":"V Kapil","year":"2014","unstructured":"Kapil V, Green J, Le Lait C, Wood D, Dargan P (2014) Misuse of benzodiazepines and Z-drugs in the UK. Br J Psychiatry 205:407\u2013408","journal-title":"Br J Psychiatry"},{"key":"2550_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.drugalcdep.2014.06.044","volume":"143","author":"M Vijayaraghavan","year":"2014","unstructured":"Vijayaraghavan M, Freitas D, Miaskowskiel C, Kushel M (2014) Non-medical use of non-opioid psychotherapeutic medications in a community-based cohort of HIV-infected indigent adults. Drug Alcohol Depend 143:263\u2013267","journal-title":"Drug Alcohol Depend"},{"key":"2550_CR16","unstructured":"EMCDDA. PERSPECTIVES ON DRUGS The misuse of benzodiazepines among high-risk opioid users in Europe [Internet]. 2015 [cited 2017 Jul 5]. Available from: \n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2733\/Misuse\n                    \n                   of benzos_POD2015.pdf"},{"key":"2550_CR17","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.addbeh.2013.05.008","volume":"38","author":"M Vogel","year":"2013","unstructured":"Vogel M, Kn\u00f6pfli B, Schmid O, Prica M, Strasser J, Prieto L, Wiesbeck GA, D\u00fcrsteler-MacFarland KM (2013) Treatment or \u201chigh\u201d: benzodiazepine use in patients on injectable heroin or oral opioids. Addict Behav 38:2477\u20132484","journal-title":"Addict Behav"},{"key":"2550_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1300\/J251v05n03_05","volume":"5","author":"E Maddahian","year":"1986","unstructured":"Maddahian E, Newcomb MDBP (1986) Adolescents\u2019 substance use: impact of ethnicity, income, and availability. Adv Alcohol Subst Abus 5:63\u201378","journal-title":"Adv Alcohol Subst Abus"},{"key":"2550_CR19","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1046\/j.1360-0443.2000.951116798.x","volume":"95","author":"C Coffey","year":"2000","unstructured":"Coffey C, Lynskey M, Wolfe R, Patton G (2000) Initiation and progression of cannabis use in a population-based Australian adolescent longitudinal study. Addiction 95:1679\u20131690","journal-title":"Addiction"},{"key":"2550_CR20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0306-4603(02)00291-5","volume":"27","author":"DJ Korf","year":"2002","unstructured":"Korf DJ (2002) Dutch coffee shops and trends in cannabis use. Addict Behav 27:851\u2013866","journal-title":"Addict Behav"},{"key":"2550_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Ph D et al (2015) Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 372:241\u2013248","journal-title":"N Engl J Med"},{"key":"2550_CR22","unstructured":"The National Center on, Abuse A and S. UNDER THE COUNTER: THE DIVERSION AND ABUSE OF CONTROLLED PRESCRIPTION DRUGS IN THE U.S. [Internet]. Columbia; 2005. Available from: \n                    https:\/\/www.centeronaddiction.org\/addiction-research\/reports\/under-counter-diversion-and-abuse-controlled-prescription-drugs-us"},{"key":"2550_CR23","unstructured":"Wood DM, Heyerdahl F, Yates CB, Dines AM, Giraudon I, Hovda KE et al The European drug emergencies. Network (Euro-DEN)"},{"key":"2550_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3109\/15563650.2015.1088157","volume":"53","author":"M Dines","year":"2015","unstructured":"Dines M, Wood D, Yates C, Heyerdahl F, Knut E, Giraudon I et al (2015) Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European drug emergencies network (Euro-DEN). Clin Toxicol 53:893\u2013900","journal-title":"Clin Toxicol"},{"key":"2550_CR25","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Hospital emergency presentations and acute drug toxicity in Europe [Internet]. 2016. Available from: \n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2973\/TD0216713ENN-1_Final\n                    \n                   pdf.pdf"},{"key":"2550_CR26","unstructured":"Yamamoto T. Euro-DEN analysis on emergency department presentations related to benzodiazepine and heroin use."},{"key":"2550_CR27","doi-asserted-by":"crossref","unstructured":"Moeller KE, Lee KC KJ. Urine drug screening: practical guide for clinicians. 2008;7231:66\u201376","DOI":"10.4065\/83.1.66"},{"key":"2550_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","volume":"90","author":"SC Licata","year":"2008","unstructured":"Licata SC, Rowlett JK (2008) Abuse and dependence liability of benzodiazepine-type drugs: GABA-A receptor modulation and beyond. Pharmacol Biochem Behav 90:74\u201389","journal-title":"Pharmacol Biochem Behav"},{"key":"2550_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.drugalcdep.2014.04.016","volume":"140","author":"J Schuermeyer","year":"2014","unstructured":"Schuermeyer J, Salomonsen-Sautel S, Price RK, Balan S, Thurstone C, Min SJ, Sakai JT (2014) Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11. Drug alcohol depend. [Internet]. Elsevier Ireland Ltd 140:145\u2013155 Available from: \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.04.016","journal-title":"Elsevier Ireland Ltd"},{"key":"2550_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/02791072.2014.916833","volume":"46","author":"R Daniulaityte","year":"2014","unstructured":"Daniulaityte R, Falck R, Carlson RG (2014) Sources of pharmaceutical opioids for non-medical use among young adults. J Psychoactive Drugs 46:198\u2013207. \n                    https:\/\/doi.org\/10.1080\/02791072.2014.916833","journal-title":"J Psychoactive Drugs"},{"key":"2550_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s13181-012-0241-3","volume":"8","author":"DM Wood","year":"2012","unstructured":"Wood DM, Dargan PI (2012) Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs. J Med Toxicol 8:300\u2013303","journal-title":"J Med Toxicol"},{"key":"2550_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/FTD.0b013e31825b954b","volume":"34","author":"DM Wood","year":"2012","unstructured":"Wood DM, Dargan P (2012) Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances. Ther Drug Monit 34:363\u2013367","journal-title":"Ther Drug Monit"},{"key":"2550_CR33","doi-asserted-by":"crossref","unstructured":"Heyerdahl F, Hovda KE, Giraudon I, Yates C, Dines AM, Sedefov R et al (2014) Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations. Clin Toxicol (Phila) 52:1005\u20131012","DOI":"10.3109\/15563650.2014.976792"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2550-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2550-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2550-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T19:21:11Z","timestamp":1569093671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2550-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,22]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["2550"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2550-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,22]]},"assertion":[{"value":"19 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"PD and DW have received financial and statistical support to undertake population and web monitoring studies on the non-medical use of prescription and non-prescription medicines in the UK and Singapore and travel and honorarium costs to attend and present at the Annual RADARS International Symposium and Scientific Meeting from the RADARS System, Denver Health and Hospital Authority, Denver, US.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}